tradingkey.logo
tradingkey.logo
Buscar

Amneal Pharmaceuticals Inc

AMRX
Añadir a la lista de seguimiento
12.308USD
-0.082-0.66%
Horarios del mercado ETCotizaciones retrasadas 15 min
3.87BCap. mercado
31.74P/E TTM

Amneal Pharmaceuticals Inc

12.308
-0.082-0.66%

Más Datos de Amneal Pharmaceuticals Inc Compañía

Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.

Información de Amneal Pharmaceuticals Inc

Símbolo de cotizaciónAMRX
Nombre de la empresaAmneal Pharmaceuticals Inc
Fecha de salida a bolsaNov 18, 2009
Director ejecutivoPatel (Chintu)
Número de empleados8100
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 18
Dirección400 Crossing Boulevard, 3rd Floor
CiudadBRIDGEWATER
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal08807
Teléfono19089473120
Sitio Webhttps://amneal.com/
Símbolo de cotizaciónAMRX
Fecha de salida a bolsaNov 18, 2009
Director ejecutivoPatel (Chintu)

Ejecutivos de Amneal Pharmaceuticals Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Chintu Patel
Mr. Chintu Patel
Co-Chief Executive Officer, Co-Founder, Director
Co-Chief Executive Officer, Co-Founder, Director
26.14M
+2.01%
Mr. Gautam Patel
Mr. Gautam Patel
Director
Director
1.64M
+2.12%
Mr. Anastasios G. (Tasos) Konidaris
Mr. Anastasios G. (Tasos) Konidaris
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
449.43K
-38.37%
Ms. Nikita Shah
Ms. Nikita Shah
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
399.79K
+52.12%
Mr. Shlomo Yanai
Mr. Shlomo Yanai
Independent Director
Independent Director
320.80K
+10.85%
Ms. Deborah M. (Deb) Autor
Ms. Deborah M. (Deb) Autor
Independent Director
Independent Director
93.66K
--
Buchi (J Kevin)
Buchi (J Kevin)
Independent Director
Independent Director
--
--
Mr. Andrew S. Boyer
Mr. Andrew S. Boyer
Executive Vice President, Chief Commercial Officer - Generics
Executive Vice President, Chief Commercial Officer - Generics
--
--
Mr. Chirag Patel
Mr. Chirag Patel
President, Co-Chief Executive Officer, Co-Founder, Director
President, Co-Chief Executive Officer, Co-Founder, Director
--
--
Mr. Ted Nark
Mr. Ted Nark
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Chintu Patel
Mr. Chintu Patel
Co-Chief Executive Officer, Co-Founder, Director
Co-Chief Executive Officer, Co-Founder, Director
26.14M
+2.01%
Mr. Gautam Patel
Mr. Gautam Patel
Director
Director
1.64M
+2.12%
Mr. Anastasios G. (Tasos) Konidaris
Mr. Anastasios G. (Tasos) Konidaris
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
449.43K
-38.37%
Ms. Nikita Shah
Ms. Nikita Shah
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
399.79K
+52.12%
Mr. Shlomo Yanai
Mr. Shlomo Yanai
Independent Director
Independent Director
320.80K
+10.85%
Ms. Deborah M. (Deb) Autor
Ms. Deborah M. (Deb) Autor
Independent Director
Independent Director
93.66K
--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de abr
Divisa: USDActualizado: lun., 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Oral solid
726.38M
24.06%
Distribution
408.46M
13.53%
Central Nervous System
333.42M
11.04%
Government label
270.11M
8.95%
Other dosage forms
252.42M
8.36%
Otro
1.03B
34.05%
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Oral solid
726.38M
24.06%
Distribution
408.46M
13.53%
Central Nervous System
333.42M
11.04%
Government label
270.11M
8.95%
Other dosage forms
252.42M
8.36%
Otro
1.03B
34.05%

Estadísticas de accionistas

Actualizado: hace 15 horas
Actualizado: hace 15 horas
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Patel (Tushar Bhikhubhai)
15.23%
Patel (Chintu)
8.19%
Patel (Chirag K)
7.10%
Akram (Mahesh)
6.44%
Patel (Dipan)
5.30%
Otro
57.73%
Accionistas
Accionistas
Proporción
Patel (Tushar Bhikhubhai)
15.23%
Patel (Chintu)
8.19%
Patel (Chirag K)
7.10%
Akram (Mahesh)
6.44%
Patel (Dipan)
5.30%
Otro
57.73%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
44.13%
Investment Advisor
19.79%
Investment Advisor/Hedge Fund
12.69%
Hedge Fund
11.08%
Private Equity
3.86%
Research Firm
2.61%
Pension Fund
0.72%
Bank and Trust
0.42%
Sovereign Wealth Fund
0.28%
Otro
4.42%

Participación institucional

Actualizado: mié., 1 de abr
Actualizado: mié., 1 de abr
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q1
521
161.64M
50.67%
-25.72M
2025Q4
448
154.72M
55.65%
+68.38K
2025Q3
455
154.66M
56.61%
+8.55M
2025Q2
432
145.89M
53.25%
+6.99M
2025Q1
416
138.78M
50.16%
-18.42M
2024Q4
398
129.01M
49.64%
-14.17M
2024Q3
380
143.02M
47.07%
+6.97M
2024Q2
372
135.82M
34.71%
+37.56M
2024Q1
356
97.40M
32.81%
-3.83M
2023Q4
348
89.35M
29.61%
+7.08M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Patel (Tushar Bhikhubhai)
48.58M
15.23%
-5.00M
-9.33%
Mar 14, 2025
Patel (Chintu)
26.14M
8.19%
+524.49K
+2.05%
Mar 12, 2026
Patel (Chirag K)
22.66M
7.1%
+535.49K
+2.42%
Mar 12, 2026
Akram (Mahesh)
20.56M
6.44%
-6.30M
-23.45%
Mar 31, 2025
Patel (Dipan)
16.90M
5.3%
-6.92M
-29.06%
Dec 31, 2025
Rubric Capital Management LP
12.33M
3.87%
--
--
Dec 31, 2025
TPG Capital, L.P.
12.33M
3.86%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
11.57M
3.63%
+231.50K
+2.04%
Dec 31, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Invesco Pharmaceuticals ETF
3.08%
State Street SPDR S&P Pharmaceuticals ETF
2.01%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2%
Invesco Dorsey Wright Healthcare Momentum ETF
0.99%
Invesco Dorsey Wright SmallCap Momentum ETF
0.83%
First Trust NASDAQ Pharmaceuticals ETF
0.78%
First Trust Small Cap Growth AlphaDEX Fund
0.72%
iShares U.S. Pharmaceuticals ETF
0.68%
ProShares Ultra Nasdaq Biotechnology
0.48%
WisdomTree US SmallCap Fund
0.36%
Ver más
Invesco Pharmaceuticals ETF
Proporción3.08%
State Street SPDR S&P Pharmaceuticals ETF
Proporción2.01%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proporción2%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporción0.99%
Invesco Dorsey Wright SmallCap Momentum ETF
Proporción0.83%
First Trust NASDAQ Pharmaceuticals ETF
Proporción0.78%
First Trust Small Cap Growth AlphaDEX Fund
Proporción0.72%
iShares U.S. Pharmaceuticals ETF
Proporción0.68%
ProShares Ultra Nasdaq Biotechnology
Proporción0.48%
WisdomTree US SmallCap Fund
Proporción0.36%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI